Nezami, Mohammad A, MD

Physicians & Surgeons, Physicians & Surgeons, Cardiology, Physicians & Surgeons, Dermatology

Be the first to review!

CLOSED NOW

Today: 9:00 am - 5:00 pm

(559) 439-5393Call Visit WebsiteVisit Website Map & DirectionsDirections1680 E Herndon AveFresno, CA 93720 Write a ReviewWrite Review

Is this your business?

Customize this page.

Claim This Business

Hours

Regular Hours

Mon - Fri:	9:00 am - 5:00 pm

Places Near Fresno with Physicians & Surgeons

Clovis (5 miles)
Calwa (14 miles)

Accepted Insurance

Nezami, Mohammad A, MD has not yet specified accepted insurance plans.

Specialties

Additional Specialties: Family Practice

GalleryView all (1)

Gallery Image Number 1

Reviews

Hi there!
Be the first to review!

Click to Rate

Details

Phone: (559) 439-5393

Address: 1680 E Herndon Ave, Fresno, CA 93720

Website: http://allcancercare.com

People Also Viewed

View similar Physicians & Surgeons

Suggest an Edit

Nezami, Mohammad A, MD

General Practitioners

Nutritional Counseling
5. M. A. Nezami, M.D, Victoria Kubal MS, BCBA, John Monteleone M.D., MPH Davin Young Clarke M.A., “Effects of Exercise Prescription and Nutrition Counseling on Patients at Risk for Cardiovascular Disease”Invited presenter, 3rd annual colloquium
Family Practice
Catherine is a licensed registered nurse whose 19 years of clinical experience is multifaceted, including surgical, medical and family medicine. She is an alumni of Tompkins- Cortland School of Nursing in New York.
Emergency Care
Dr. Sherri J. Tenpenny is an osteopathic medical doctor, board certified in three medical specialties. From 1986 to 1998, she was a full time Emergency Medicine physician and the director of the Emergency Department in Findlay, Ohio.
Infectious Diseases
44. M. Nezami MD, Vicky Yamamoto, PhD, " Biological disruptive therapies as counter measures for unpredictable biological insults, A case for successful treatment of Covid 19", journal of Infectious Diseases( AID), SCRIP, August 2020, DOI: 10.4236/aid.2020.103018
Electrocardiogram
Mario, has worked for Pacific/Orange Coast Medical Center of Hope since July 2010. Graduated from the Institute of Technology, California in 2007 in Web & Graphic Design. Following, attended and graduated from UEI College, as a EKG technician & Medical Assistant.

Gynecology
In a bid to resensitize patients to carboplatin, Nephew and Matei and co-investigator Jeanne M. Schilder, M.D., associate professor of obstetrics and gynecology in the Division of Gynecologic Oncology at the IU School of Medicine, turned to the DNA demethylating agent, decitabine.
Obstetrics

Internal Medicine
He promotes patient participation in clinical trials whenever clinically appropriate. Board ceritified in internal medicine, medical oncology and hematology.
Kidney Cancer
Cancer has been and is a prevalent disease with generally poor outcome. About 1.7 million new cancer cases( which translates to about 1,670 deaths per day) were diagnosed in 2020, and 700 thousand died, just in the US alone. This estimate does not include carcinoma in situ (noninvasive cancer) of any site except urinary bladder, nor does it include basal cell or squamous cell skin cancers because these are not required to be reported to cancer registries. The ten most commonly diagnosed cancers among men in the United States included cancers of the prostate, lung, colon rectum, and bladder; melanomas of the skin; Non-Hodgkin's lymphoma; kidney cancer, mouth and throat cancer, leukemia, and pancreatic cancer and the incidence has been almost unchanged over the previous 8 years. The incidence of cancer in younger individuals is actually on the rise. Of 91 new therapies approved for solid tumors between 2002 and 2016, the median overall survival benefit was little more than two months. Yet the annual price tag per patient now regularly exceeds $100,000 (Workman P, Draetta GF, Schellens JH, Bernards R. Cell. 2017; 168:579-583).
Ovarian Cancer
Following is a sample of a report that he provided a patient with recurrent aggressive ovarian cancer, when there was confusion on the treatment response and the already available/ offered treatments failed to optimally control the disease progression...
Prostate Cancer
23. Landscape of BRCA1 and BRCA2 germline, somatic, and reversion alterations detectable by cell-free DNA testing among patients with metastatic breast, ovarian, pancreatic, or prostate cancer
Cancer Care
A central theme of this program is the personalized medicine strategy, embodied in a protocol called MTET, for multi molecular modified targeted epigenetic therapy, a profile related to evidence determining customized cancer care. This approach utilizes advanced molecular technologies to match tumors with natural and non toxic cancer treatments that optimizes chances for response.
Lung Cancer
" Application of multitargeted Epigenetic therapy and review of case series in recurrent advanced Non small Cell Lung Cancer, Heterogenous approach for heterogenous disease, Heterogeneity in cancer genomics and epigenetic approach"

Neurology
Dr. Duma received his general neurosurgical training at Georgetown University Hospital in Washington, D.C., followed by a fellowship at the University of Pittsburgh Medical Center Presbyterian in Gamma Knife radiosurgery and stereotactic and functional neurosurgery. He has been involved in medical research since his undergraduate education, beginning at the Cornell University School of Medicine’s Department of Neuropharmacology and continuing on through his graduate years at Memorial Sloan-Kettering Cancer Center’s Department of Neurology Pain Service. In 2002, Dr. Duma founded The Foundation for Neurosciences, Stroke and Recovery to provide outreach and assistance to patients with movement disorders. He continues to serve as Chair of the Foundation for Neurosciences, Stroke and Recovery, and remains active in Orange County’s medical community.
Multiple Sclerosis
” Improved symptoms of multiple sclerosis in response to nutritional therapy: an integrative approach to neurodegenerative disorders, a case report”https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1770655/

Endocrinologist

Endocrinology
6.) Are you taking salsalates? If not you will need to start right away on 1 gram, three times a day of Salsalates. You have over expression of COX correlating with PTGS2 overexpression. Read below: http://joe.endocrinology-journals.org/content/198/2/281.full

MRI
Also the MRI of her brain before and after the therapy. The dural metastatic disease response.....The comment from her neurosurgeon: "I HAVE NEVER SEEN CARCINOMATOUS MENINGITIS RESPOND LIKE THIS..... BRAVO!"
Radiology
Reza Shirazi, M.D.graduated Magna Cum Laude in Electrical Engineering and Computer Science from California State University of Los Angeles and was recipient of the 1996 NASA & Jet Propulsion Laboratories, Outstanding Engineer of the Year Award. He earned his Master’s in Applied Physiology and medical degree from The Chicago Medical School at the Rosalind Franklin University of Medicine and Science in 2001. He served his internship at Loyola University Medical Center in Chicago, and completed his residency in Radiation Oncology at the University of Cincinnati Barrett Cancer Center where he served as the chief resident from 2005-2006. He is Board Certified in Radiation Oncology by the American Board of Radiology and recipient of the RSNA 2006 Roentgen Resident/Fellow Research Award. He joined Radiation Medical Group in 2006.
Nuclear Medicine
"Multitargeted Epigenetic therapy (MTET) and hypoxia response elements, a turning point in radiation oncology, 2nd international conference on nuclear medicine and radiation oncology, July 27-28, 2017, Rome, Italy
Chemotherapy
For recurrent disease, it is even more critical to pay attention to the genetics of the tumor, as it may well have been changed by the treatments that have been received. For example when a cancer metastasizes, the new tumor in a different site may have different genetics. Every time a patient is receiving chemotherapy, this treatment can change the genetics of the tumor.
Radiation Therapy
Due to his expertise in the area of epigenetic science and oncology, he has recently been honored to serve as the organizer, key note speaker, board member and chair for several national and international oncology conferences.( ex. SBMT, Radiation oncology and anti cancer therapy, International Conference on Nuclear Medicine and radiation therapy,...)
Radiation Oncology

Neurosurgery
Beach, Calif. He also serves as assistant clinical professor of neurosurgery at the University of California, Irvine’s School of Medicine as well as director of radiosurgery for UCI Medical Center’s Department of Neurosurgery residency training program. His affiliations include Mission Hospital in Laguna Beach, UCI Medical Center in Orange, and Orange Coast Memorial Medical Center in Fountain Valley.

Skin Cancer
89. "Epigenetic role in metastatic melanoma carcinogenesis and treatment response", Fifth middle east international dermatology conference and exhibition, Dubai, UAE, December, 2020
Dermatology
Lesions
50. Peer Review expert, Journal of Advancements in Medicine and medical research, Science Domain, Apr, 2018 "“Space Occupying Lesions (SOL) of brain - Clinical manifestation with subtle neurological symptoms in Emergency Department.”

View All Services

Provided by